# Notice of Intent to Sole-Source T-SPOT.TB® Reagents and Kits Canonical: https://abierto.us/opportunities/36c24227q0036 - Solicitation number: 36C24227Q0036 - Notice type: Special notice - Status: Closed. Deadline was October 16, 2026 at 4:00 PM EDT - Department: Department of Veterans Affairs - Contracting office: 242-Network Contract Office 02 (36C242) - NAICS: 334516 Analytical Laboratory Instrument Manufacturing - Product or service code: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits and Sets - Who can bid, by location: Anywhere in the US. Location does not limit who can bid: a product shipped to the buyer, research at the performer's facility, or work at the contractor's site. A state shown is the delivery point. - First posted: October 2, 2026 - Last posted: October 2, 2026 - SAM.gov: https://sam.gov/workspace/contract/opp/d50ba2f2eb5a4791a7ce9e599cc69cbf/view ## Description This notice is being published in accordance with Revolutionary FAR Overhaul Federal Acquisition Regulation (RFO FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. The Department of Veterans Affairs, Network Contracting Office (NCO) 2, hereby provides notice of its intent to award a sole source, firm fixed price contract to Euroimmun US Incorporated, the sole authorized U.S. distributor of T SPOT.TB® reagents and associated kits manufactured by Oxford Immunotec. These reagents are required for tuberculosis testing at VA Western New York Healthcare System (VAWNYHS) Buffalo VA Medical Center (VAMC). This determination is made in accordance with RFO FAR 12.201-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The T SPOT.TB® assay is a patented IGRA platform, and its reagents including the antigen panels, controls, and AIM V media are proprietary and FDA cleared only for use with the OEM platform. Oxford Immunotec holds the exclusive patent rights, and Euroimmun US Incorporated is the only supplier legally authorized to provide these FDA approved reagents for federal healthcare facilities. No other vendor can supply reagents that meet FDA, CLIA, CAP, and Joint Commission requirements. This notice is not a request for competitive quotes. However, interested parties may identify their interest and capability to respond to this requirement by submitting a: Capability Statement (1 page maximum) Company Name UEI Number Socioeconomic Status Proof of authorization to provide the OEM reagents Responses must be received no later than 4:00 PM EST on October 16, 2026 to Myra.Green2@va.gov A determination not to compete this proposed action is solely within the discretion of the Government. Information received will only be considered for determining whether to conduct a competitive procurement in the future. Prospective contractors must be registered in SAM.gov to be eligible for award. ## Attachments - [36C24227Q0036 Notice of Intent to Sole Source.pdf](https://sam.gov/api/prod/opps/v3/opportunities/resources/files/904665ed7efd46a39a3da1216b052e5b/download) ## Open now in the same industry 39 open in NAICS 334516. - Electrophoresis Testing for the Albany, Buffalo, and Syracuse VA Medical Centers (36C24226Q0949), due November 2, 2026 at 3:00 PM EST. https://abierto.us/opportunities/36c24226q0949 - Volumetric KF Titrator (N6893626SIMACQD5550000062), due November 3, 2026 at 1:00 PM EST. https://abierto.us/opportunities/n6893626simacqd5550000062 - 170 Composite Cylinders for KSC SCAPE Operations (80NSSC27948373Q), due November 4, 2026 at 3:30 PM EST. https://abierto.us/opportunities/80nssc27948373q ## Publications - October 2, 2026: Special notice, due October 16, 2026 at 4:00 PM EDT. Notice d50ba2f2eb5a4791a7ce9e599cc69cbf. https://sam.gov/workspace/contract/opp/d50ba2f2eb5a4791a7ce9e599cc69cbf/view ## Points of contact - Myra F. Green, Contracting Officer, Myra.Green2@va.gov --- Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/36c24227q0036.